FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Gennadios Aristippos
2. Issuer Name and Ticker or Trading Symbol

Catalent, Inc. [ CTLT ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
President, Softgel Tech.
(Last)          (First)          (Middle)

C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD
3. Date of Earliest Transaction (MM/DD/YYYY)

8/22/2019
(Street)

SOMERSET, NJ 08873
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock  8/22/2019    A(1)    12420  A $0  48037 (2) D   
Common Stock  8/22/2019    F    3805  D $55.24  44232 (2) D   

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:
(1)  Received upon the achievement of the fiscal 2017-19 performance-based vesting criteria set forth in certain incentive compensation held by the reporting person under the issuer's long-term incentive plan.
(2)  Includes restricted stock units.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Gennadios Aristippos
C/O CATALENT, INC.
14 SCHOOLHOUSE ROAD
SOMERSET, NJ 08873


President, Softgel Tech.

Signatures
/s/ Stephanie L. Mariconda, attorney-in-fact 8/26/2019
**Signature of Reporting Person Date


Catalent (NYSE:CTLT)
Historical Stock Chart
Von Jun 2024 bis Jul 2024 Click Here for more Catalent Charts.
Catalent (NYSE:CTLT)
Historical Stock Chart
Von Jul 2023 bis Jul 2024 Click Here for more Catalent Charts.

News Catalent, Inc.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Catalent Completes $25 Million Expansion of its Clinical Supply Facility in Schorndorf, Germany
Dienstag 16 Juli 2024 (11 Stunden vor) • Business Wire
Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 6 Juni 2024 (1 Monat vor) • Edgar (US Regulatory)
Form 144 - Report of proposed sale of securities
Dienstag 4 Juni 2024 (1 Monat vor) • Edgar (US Regulatory)
Form 8-K - Current report
Mittwoch 29 Mai 2024 (2 Monate vor) • Edgar (US Regulatory)
Catalent Stockholders Approve Transaction with Novo Holdings
Mittwoch 29 Mai 2024 (2 Monate vor) • Business Wire
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Donnerstag 16 Mai 2024 (2 Monate vor) • Edgar (US Regulatory)
Form 8-K - Current report
Donnerstag 16 Mai 2024 (2 Monate vor) • Edgar (US Regulatory)
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 8 Mai 2024 (2 Monate vor) • Edgar (US Regulatory)
Form 8-K - Current report
Mittwoch 8 Mai 2024 (2 Monate vor) • Edgar (US Regulatory)
Catalent, Inc. Reports Third Quarter Fiscal 2024 Results
Mittwoch 8 Mai 2024 (2 Monate vor) • Business Wire
Perficient Stock Soars 52.9% Post-Acquisition; Luminar Declines 10% Amid Workforce Cutbacks, and Other News
Montag 6 Mai 2024 (2 Monate vor) • IH Market News
Tesla Resolves Autopilot Lawsuit, JPMorgan Unveils Potential CEO Successors, and More
Dienstag 9 April 2024 (3 Monate vor) • IH Market News